Works matching IS 00071048 AND DT 2023 AND VI 201 AND IP 2
Results: 29
'A novel approach for characterisation of KSHV‐associated multicentric Castleman disease from effusions': Response.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 360, doi. 10.1111/bjh.18699
- By:
- Publication type:
- Article
How I manage mantle cell lymphoma: indolent versus aggressive disease.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 185, doi. 10.1111/bjh.18697
- By:
- Publication type:
- Article
The continuing global challenges of treating patients with beta‐thalassemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 183, doi. 10.1111/bjh.18769
- By:
- Publication type:
- Article
Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody‐mediated haemolytic anaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 364, doi. 10.1111/bjh.18710
- By:
- Publication type:
- Article
Reply to Zhou et al. 'A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions'.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 357, doi. 10.1111/bjh.18698
- By:
- Publication type:
- Article
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 353, doi. 10.1111/bjh.18696
- By:
- Publication type:
- Article
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. e16, doi. 10.1111/bjh.18693
- By:
- Publication type:
- Article
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. e12, doi. 10.1111/bjh.18688
- By:
- Publication type:
- Article
Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID‐19 in a tertiary center – A monocentric analysis.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 222, doi. 10.1111/bjh.18686
- By:
- Publication type:
- Article
A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 302, doi. 10.1111/bjh.18681
- By:
- Publication type:
- Article
Thalassaemia—A global view.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 199, doi. 10.1111/bjh.18671
- By:
- Publication type:
- Article
The value of bone marrow aspiration during analysis of fever, pancytopenia and splenomegaly: Diagnosing visceral leishmaniasis.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 179, doi. 10.1111/bjh.18668
- By:
- Publication type:
- Article
Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS‐CoV‐2 and non‐SARS‐CoV‐2 vaccination: 32 Years of passive surveillance data.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 227, doi. 10.1111/bjh.18627
- By:
- Publication type:
- Article
Prognostic factors in patients in the terminal phase of haematological malignancies who are receiving home medical care.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 290, doi. 10.1111/bjh.18623
- By:
- Publication type:
- Article
Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 249, doi. 10.1111/bjh.18618
- By:
- Publication type:
- Article
How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer‐directed therapies.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 215, doi. 10.1111/bjh.18661
- By:
- Publication type:
- Article
β‐Thalassemia in childhood: Current state of health in a high‐income country.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 334, doi. 10.1111/bjh.18631
- By:
- Publication type:
- Article
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 280, doi. 10.1111/bjh.18630
- By:
- Publication type:
- Article
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK‐cell counts in rituximab–chemotherapy responsive elderly DLBCL patients: A LYSA group study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 256, doi. 10.1111/bjh.18642
- By:
- Publication type:
- Article
Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 319, doi. 10.1111/bjh.18640
- By:
- Publication type:
- Article
Genome‐wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 343, doi. 10.1111/bjh.18637
- By:
- Publication type:
- Article
Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 285, doi. 10.1111/bjh.18617
- By:
- Publication type:
- Article
Maintenance therapy in multiple myeloma: Two is not always better than one.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 181, doi. 10.1111/bjh.18614
- By:
- Publication type:
- Article
Acquired Haemophilia A in four north European countries: survey of 181 patients.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 326, doi. 10.1111/bjh.18611
- By:
- Publication type:
- Article
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 308, doi. 10.1111/bjh.18610
- By:
- Publication type:
- Article
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 234, doi. 10.1111/bjh.18608
- By:
- Publication type:
- Article
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open‐label, randomised, phase III trial.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 267, doi. 10.1111/bjh.18600
- By:
- Publication type:
- Article
Bullous pemphigoid‐like rash induced by bendamustine.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 180, doi. 10.1111/bjh.18592
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 175, doi. 10.1111/bjh.18257
- Publication type:
- Article